Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

about

Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge.Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.Immunity and HER2-positive disease: never stop questioning.

P2860

Q38786102-10B55F44-522F-4622-90B2-BF754F77269F Q48102534-7220EC1A-7544-4280-9263-C4D5BD2216AC Q55038495-51E9E9B3-B41D-4E4C-93D0-7F0C025FD82B

P2860

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

Item

http://www.wikidata.org/entity/Q42923134

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@en

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@nl

type

Item

label

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@en

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@nl

prefLabel

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@en

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

@nl

P1476

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls

@en

P2093

Katherine L Pogue-Geile

http://www.w3.org/2001/XMLSchema#string

Nan Song

http://www.w3.org/2001/XMLSchema#string

S Rim Kim

http://www.w3.org/2001/XMLSchema#string

Soonmyung Paik

http://www.w3.org/2001/XMLSchema#string

P2860

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

P304

3671-3672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.61.9650

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick G Gavin

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26282639

http://www.w3.org/2001/XMLSchema#string

P932

4816211

http://www.w3.org/2001/XMLSchema#string

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

about

P2860

P2860

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932